Anavex Life Sciences Corp (AVXL)

[TempePhil]

Spoke with company 8/21/2019.....
Tried to get some answers to overview type questions, nothing technical or detailed. The company representative was very open and ready to answer any question that could be commented on.

Has the peer reviewed paper been published, or what is the publication name or time frame for it? Ans. No, it has not been published, and no comment on the publication or time frame.

Will full enrollment announcement be made immediately or at a conference? Ans. It will probably be an immediate PR announcement.

How many employees does the company now have? Ans. Under 20. Between 10-20.

Why was the shelf announcement made after hours right before a holiday? Ans. That was when the process was finished and info was available. The company says there is no intent to use this shelf money now, but it is available in case of good trial results and more trials need to be run.

General discussion...The company continues to try to run lean and frugally. The trials were delayed because Dr.M saw all these large expensive Alz trials failing and he decided to try to do them smarter using PM, even if it delayed the trials. The advantage being the trials would be less expensive and require fewer people. This is continued to be seen as the year of execution, with lots riding on read outs.